MISC

査読有り
2012年3月

Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: Usefulness of virtual CT sonography with magnetic navigation

EUROPEAN JOURNAL OF RADIOLOGY
  • Yasunori Minami
  • ,
  • Satoshi Kitai
  • ,
  • Masatoshi Kudo

81
3
開始ページ
E277
終了ページ
E280
記述言語
英語
掲載種別
DOI
10.1016/j.ejrad.2011.02.026
出版者・発行元
ELSEVIER IRELAND LTD

Purpose: Virtual CT sonography using magnetic navigation provides cross sectional images of CT volume data corresponding to the angle of the transducer in the magnetic field in real-time. The purpose of this study was to clarify the value of this virtual CT sonography for treatment response of radiofrequency ablation for hepatocellular carcinoma.
Patients and methods: Sixty-one patients with 88 HCCs measuring 0.5-1.3 cm (mean +/- SD, 1.0 +/- 0.3 cm) were treated by radiofrequency ablation. For early treatment response, dynamic CT was performed 1-5 days (median, 2 days). We compared early treatment response between axial CT images and multi-angle CT images using virtual CT sonography.
Results: Residual tumor stains on axial CT images and multi-angle CT images were detected in 11.4% (10/88) and 13.6% (12/88) after the first session of RFA, respectively (P = 0.65). Two patients were diagnosed as showing hyperemia enhancement after the initial radiofrequency ablation on axial CT images and showed local tumor progression shortly because of unnoticed residual tumors. Only virtual CT sonography with magnetic navigation retrospectively showed the residual tumor as circular enhancement. In safety margin analysis, 10 patients were excluded because of residual tumors. The safety margin more than 5 mm by virtual CT sonographic images and transverse CT images were determined in 71.8% (56/78) and 82.1% (64/78), respectively (P = 0.13). The safety margin should be overestimated on axial CT images in 8 nodules.
Conclusion: Virtual CT sonography with magnetic navigation was useful in evaluating the treatment response of radiofrequency ablation therapy for hepatocellular carcinoma. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

リンク情報
DOI
https://doi.org/10.1016/j.ejrad.2011.02.026
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000300408100019&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.ejrad.2011.02.026
  • ISSN : 0720-048X
  • Web of Science ID : WOS:000300408100019

エクスポート
BibTeX RIS